Methadone Hydrochloride Tablets for Oral Suspension
» Methadone Hydrochloride Tablets for Oral Suspension contain not less than 93.0 percent and not more than 107.0 percent of the labeled amount of methadone hydrochloride (C21H27NO·HCl).
Packaging and storage— Preserve in well-closed containers.
Labeling— Label the Tablets for Oral Suspension to indicate that they are intended for dispersion in a liquid prior to oral administration of the prescribed dose.
Identification— A quantity of powdered Tablets for Oral Suspension, equivalent to about 5 mg of methadone hydrochloride, responds to Identification test A under Methadone Hydrochloride Oral Solution.
Disintegration 701: 15 minutes.
Uniformity of dosage units 905: meet the requirements.
Assay—
Mobile phase— Prepare a filtered and degassed mixture of 0.03 M monobasic potassium phosphate and acetonitrile (60:40). Adjust with phosphoric acid to a pH of 3.2. Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Dissolve an accurately weighed quantity of USP Methadone Hydrochloride RS in Mobile phase to obtain a solution having a known concentration of about 0.4 mg per mL.
Assay preparation— Weigh and finely powder not fewer than 20 Tablets for Oral Suspension. Transfer an accurately weighed portion of the powder, equivalent to about 10 mg of methadone hydrochloride, to a 25-mL volumetric flask. Add 10 mL of Mobile phase, and sonicate briefly. Shake by mechanical means for 15 minutes, dilute with Mobile phase to volume, mix, and filter.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 254-nm detector and a 3.9-mm × 30-cm column that contains packing L11. The flow rate is about 1.5 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor is not more than 2.0, and the relative standard deviation is not more than 2.0%.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of methadone hydrochloride (C21H27NO·HCl) in the portion of Tablets for Oral Suspension taken by the formula:
25C(rU / rS)
in which C is the concentration, in mg per mL, of USP Methadone Hydrochloride RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Clydewyn M. Anthony, Ph.D.
Scientist
1-301-816-8139
(MDCCA05) Monograph Development-Cough Cold and Analgesics
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
701 Margareth R.C. Marques, Ph.D.
Senior Scientist
1-301-816-8106
(BPC05) Biopharmaceutics05
USP32–NF27 Page 2916
Pharmacopeial Forum: Volume No. 28(6) Page 1821